Doppler echocardiography is commonly used to estimate systolic nose PH in patients with advanced lung disease is preferable.
DE and RHC as part of their evaluation. Using this large cohort of patients, the aim of this study was to examine the Pulmonary hypertension (PH) is a common feature signaling performance characteristics of DE in estimating sPAP and the advanced stages of diseases of the pulmonary vasculature, detecting the presence of PH. parenchyma, and airways. Detection of the presence of PH provides valuable prognostic information and dictates the need METHODS for such therapies as vasodilators and supplemental oxygen (1-3). Moreover, the magnitude of PH influences decisions Consecutive patients with advanced lung disease who underwent an on the appropriateness of surgical options for treatment of evaluation for lung transplantation between January 1991 and Decemadvanced lung disease. In this regard, the presence of signifiber 2000 were screened. The study population included all patients who cant PH often prompts consideration of lung transplantation had DE and RHC within 72 hours of each other during a formal evaluation process. DE was typically performed 24-48 hours before RHC in the appropriate setting (4). Conversely, PH is considered according to our transplant evaluation protocol. The studies were pera contraindication to lung volume reduction surgery for adformed independently by operators who had no knowledge of the results vanced emphysema (5).
of the other study. The clinical status and treatment of these patients Although pulmonary artery pressures and other cardiac were unaltered during the evaluation period.
hemodynamic parameters can be accurately assessed by right heart catheterization (RHC), a simple, reliable, and noninva-
DE Technique
sive method to estimate pulmonary artery pressures and diag- tion, m/second) (7, 9, 15) . by DE and that measured by RHC (r ϭ 0.69, p Ͻ 0.0001 by Pearson correlation) ( Figure 2 ). Likewise, the intraclass correlation was strong (r ϭ 0.60, p Ͻ 0.0001).
We observed a significant discrepancy between RAP esti-0.018). (Figure 3 ). When DE-estiinferior vena caval collapse). To determine whether the estimamated sPAP was recalculated using RAP measured by RHC tion of RAP by DE impacted significantly on the correlation rather than estimated RAP, the overall accuracy of DE improved between estimated and measured sPAP, the actual RAP meaonly modestly (55% accuracy compared with 48% when estisurements obtained by RHC were used to recalculate DE-estimated RAP was used). mated sPAP values. The correlation coefficient improved only Conversely, when estimated sPAP was 45 mm Hg or more by slightly when RAP measured by RHC was substituted for that DE, it was accurate in only 31% of the studies compared with estimated by DE and DE sPAP was recalculated (r ϭ 0.74, p Ͻ 72% of studies in which estimated sPAP was less than 45 mm 0.0001).
Hg (p Ͻ 0.0001). Importantly, 48 of 99 patients (48%) with sPAP Despite a statistically significant correlation between sPAP of 45 mm Hg or more by DE did not have PH by RHC (Figure 1 ). estimated by DE and that measured by RHC, DE-estimated In all but four of these false-positive cases, the difference in sPAP was accurate (within 10 mm Hg of RHC measurement) sPAP obtained by the two methods was more than 10 mm Hg. in only 48% (95% CI, 40 to 56%) of the studies. Moreover, 47 of 166 (28%) studies revealed a difference between DE-esti-
Diagnosis of PH by DE
mated and RHC-measured sPAP of more than 20 mm Hg, and
We first examined the performance characteristics of DE-estiin 15 studies (9%), the difference was more than 30 mm Hg. mated sPAP in establishing or excluding a diagnosis of PH, using The accuracy of DE was higher in patients with obstructive lung RHC as the gold standard (Table 2) . PH was considered to be disease compared with those with interstitial lung disease and pulmonary vascular disease (56% versus 37% versus 20%, p ϭ present by DE when the estimated sPAP was 45 mm Hg or Definition of abbreviations: ILD ϭ interstitial lung disease; NPV ϭ negative predictive value; OLD ϭ obstructive lung disease; PPV ϭ positive predictive value; RV ϭ right ventricular; sPAP ϭ systolic pulmonary artery pressure.
* Defined as the total group of patients for whom the DE finding could be ascertained (n ϭ 166 patients for whom sPAP could be estimated and n ϭ 372 patients for whom RV could be visualized).
† RV findings are defined as the presence of RV dilation, hypertrophy, or systolic dysfunction.
more. For the entire group of 166 patients for whom DE-estiThe success and accuracy of this technique are dependent on the mated sPAP could be determined, the sensitivity, specificity, and ability to identify and precisely measure the velocity of the tricuspositive and negative predictive values of estimated sPAP in dipid regurgitant jet and, therefore, are influenced by factors alteragnosing PH were 85% (95% CI, 73 to 93%), 55% (95% CI, ing the position of the heart in relationship to the DE probe, 45 to 64%), 52% (95% CI, 41 to 62%), and 87% (95% CI, 76 such as obesity and hyperinflated lungs. Intraobserver and interto 94%), respectively. observer variability and limitations in the estimation of RAP also Next, the performance characteristics of DE-identified right impact the accuracy of this technique. The use of this technique ventricular abnormalities as a surrogate diagnostic marker of has been most extensively and convincingly validated in patients PH were examined ( Table 2 ). The right ventricle was adequately with cardiac disease. In three of the largest studies, encompassing visualized in 372 of the 374 patients. When applied to this group, a total of over 250 patients, sPAP could be estimated in 59-87% the sensitivity, specificity, and positive and negative predictive of patients, and the correlation with measured sPAP was excelvalues of right ventricular abnormalities in diagnosing PH were lent, with a correlation coefficient of 0.93-0.97 (6, 7, 9) . 82% (95% CI, 73 to 89%), 57% (95% CI, 51 to 62%), 39%
In contrast to these studies, we have focused on a population (95% CI, 32 to 46%), and 90% (95% CI, 85 to 94%), rewith advanced pulmonary disease, comprised chiefly of patients spectively. The utility of using right ventricular findings in pawith severe chronic obstructive pulmonary disease and interstitients in whom sPAP could not be estimated was then specifically tial lung diseases. Our study comprises the largest cohort of pascrutinized (Figure 1) . In 208 patients in whom sPAP could not tients with pulmonary disease studied to date and both corrobobe estimated, right ventricular findings were present in 88 (42%), rates and extends observations made in previous smaller series. but only 29 of these 88 (33%) patients had PH by RHC. In 120
We have demonstrated that both the likelihood of estimating a patients who had no right ventricular findings, 115 (96%) did sPAP and the correlation with measured sPAP are lower in this not have PH by RHC. Thus, the finding of right ventricular population compared with those with cardiac disease. Regarding abnormalities led to considerable overdiagnosis of PH, but the the first issue, we were able to estimate sPAP in only 44% of absence of these abnormalities reliably excluded PH.
patients. It is likely that factors related to pulmonary disease Finally, we calculated the performance characteristics of DEcontributed significantly to this. Specifically, changes associated estimated sPAP and right ventricular abnormalities in establishwith chronic obstructive pulmonary disease, including marked ining a diagnosis of PH for each of the two main disease subgroups: crease in intrathoracic gas, expansion of the thoracic cage, and obstructive lung disease and interstitial lung disease ( Table 2) .
alterations in the position of the heart, adversely influence the Similar to the group as a whole, the specificity of these DE ability to detect and measure the velocity of the tricuspid regurgiparameters was generally lower than their sensitivity, a discreptant jet. Our demonstration that the likelihood of obtaining a ancy that was particularly apparent in relationship to DE-esti-DE-estimated sPAP was significantly lower in the subset of pamated sPAP among the interstitial lung disease group. The positients with obstructive lung disease and those with a residual tive predictive value of DE studies was low in both disease volume exceeding 150% of predicted support this claim. The subgroups. In contrast, the negative predictive value of DE stud-38% success rate in estimating sPAP in patients with obstructive ies exceeded 90% in the obstructive lung disease group, whereas lung disease falls within a range documented in several previous corresponding values were lower and more variable in the interstudies. In a study of 100 patients with chronic obstructive pulmostitial lung disease population. The universal prevalence of PH nary disease, Tramarin and colleagues obtained estimates by among patients with pulmonary vascular disease precluded cal-DE in only 30% (12) . Bach and associates documented a success culation of all but sensitivity in this group, which was 100% for rate of 26% among 207 patients with advanced chronic obstruc-DE-estimated sPAP and 93% for the presence of right ventricutive pulmonary disease undergoing evaluation for lung volume lar abnormalities. reduction surgery (11). In contrast, Laaban and colleagues obtained estimates of sPAP in 66% of 41 patients with severe chronic DISCUSSION obstructive pulmonary disease (10). Whether changes in chest wall configuration and cardiac orientation also limit DE estimation of In this study, we investigated the value of DE as a noninvasive sPAP in patients with interstitial lung diseases remains unclear. means of estimating sPAP and establishing or excluding a diagAlthough we documented a statistically significant correlation nosis of significant PH in a large cohort of patients with advanced between DE-estimated sPAP and measured values by RHC, the lung disease of various etiologies. We demonstrated a reasonably correlation coefficient of 0.69 was well below that reported in strong and statistically significant correlation between DE-estistudies involving cardiac patient populations. This suggests that mated sPAP and RHC-measured sPAP. Despite this significant there is greater variability between estimated and measured correlation, several important limitations of DE were identified.
pressures in patients with lung disease, again likely due to factors First, sPAP estimation by DE was possible in less than one-half specific to this patient population that limit accurate visualization of all patients. Second, there was a discordance of greater than and measurement of the velocity of the tricuspid regurgitant 10 mm Hg between estimated and measured sPAP in 52% of pajet. Three previous studies involving patients with pulmonary tients, and in 28%, the discordance was greater than 20 mm Hg.
disease have found similar correlation coefficients, in the range Third, DE-estimated sPAP was associated with a poor positive of 0. 65-0.73 (10-12) . One additional study documented a correlapredictive value for the diagnosis of PH, with confirmation of PH tion coefficient of 0.92, but sPAP was determined by DE in only by RHC in only one-half of those patients in whom DE suggested 24% of patients, suggesting that the patients in whom pressures its presence. Reliance on findings of right ventricular abnormaliwere estimated may have been meticulously selected (13) . In ties did not enhance the poor positive predictive value of DE.
contrast to these previous studies that focused largely on definiThe technique employed in this study to estimate sPAP by tion of a correlation coefficient as a means of characterizing the DE involves calculation of the trans-tricuspid gradient from meavariability between estimated and measured pressures, we have surement of the peak velocity of the tricuspid regurgitation jet attempted to provide a more clinically relevant parameter by using the modified Bernoulli equation (6, 7, 9, 15) . Right ventricdetermining the frequency with which estimated sPAP fell within ular pressure and, indirectly, sPAP are then determined by adding an estimated RAP to the calculated trans-tricuspid gradient.
10 mm Hg of the actual value. We found that DE provided an "accurate" (i.e., less than 10 mm Hg discrepancy) estimate of appears to be of greatest utility as an adjunctive means of excluding significant PH in patients with obstructive lung disease, parsPAP in only 48% of cases. Accuracy improved only modestly to 55% when RAP measured by RHC was substituted for estimated ticularly in situations in which sPAP cannot be estimated. One potential limitation of our study is that DE and RHC RAP in the calculation of sPAP, suggesting that errors in estimating RAP were only a minor source of the observed discrepancy.
were not performed simultaneously but rather within a 3-day window. In a study by Currie and colleagues, 43 patients underOf note, the current practice of estimating RAP by the pattern of inferior vena caval collapse resulted in overestimation of the went RHC and both simultaneous and sequential DE, with an average of 3 days separating the two DE studies (7) . Notably, the actual RAP to the same degree as did the earlier practice of universally assuming an RAP of 15 mm Hg in all patients.
trans-tricuspid gradients were not significantly different between the two DE studies, but the correlation between DE and RHC We observed significant differences in the accuracy of DE in estimating sPAP among the disease subgroups. Accuracy was pressures dropped slightly over time (r ϭ 0.97 for simultaneous DE and 0.87 for delayed DE). This study suggests that separation highest in the obstructive lung disease group compared with the groups with interstitial lung disease and pulmonary vascular disof RHC and DE by up to 3 days has at best a minimal impact. Furthermore, all patients in our study were clinically stable and ease, despite the significantly lower likelihood of obtaining an estimation of sPAP in obstructive lung disease. The reasons for observed daily with no changes in any medications made during their evaluation period. this apparent paradox are not immediately clear. It is at first tempting to speculate that this simply reflects a greater likelihood
In conclusion, estimation of sPAP by DE is frequently inaccurate (i.e., discrepant by at least 10 mm Hg) in patients with of correctly estimating within 10 mm of actual pressure when pressures are low, as in the obstructive lung disease population, underlying advanced lung disease. In light of the poor positive predictive value of DE-estimated sPAP and of findings of right as opposed to when they are moderately or markedly elevated, as encountered in the interstitial lung disease and pulmonary vascuventricular abnormalities in this population, reliance on this noninvasive technique can potentially lead to overdiagnosis of PH. lar groups. However, our finding that accuracy was similar in those with and without PH refutes this argument. Alternatively, When the exact magnitude of PH is of critical importance, such as in the assessment of patients for lung volume reduction surgiven the greater difficulties in visualizing the tricuspid regurgitant jet in patients with obstructive lung disease and hyperinflagery or lung transplantation, echocardiographic findings suggestive of PH should be confirmed by RHC. tion, the interpreting cardiologists may be biased in favor of estimating pressures more selectively; restricting these estimates
